NTI
Click for more information
1.45% 7.0¢ neurotech international limited

Ann: Last Patient Completes Treatment in NTIASD2 Clinical Trial, page-3

  1. Scrooge1
    215 Posts.
    lightbulb Created with Sketch. 62
    clock Created with Sketch.
    10/04/24
    08:45
    Post #: 73269145
    "The results of the NTIASD2 clinical trial are expected in early Q2 CY2024."

    Not long to go now! Should be in the next few of weeks.
    NTI Price at posting: 10.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
0.001(1.45%) 		Mkt cap ! $71.21M
Open High Low Value Volume
7.0¢ 7.0¢ 6.6¢ $121.1K 1.783M

Buyers (Bids)

No. Vol. Price($)
1 2700 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 117275 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.